1. Home
  2. DSY vs CRIS Comparison

DSY vs CRIS Comparison

Compare DSY & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

N/A

Current Price

$2.81

Market Cap

13.6M

Sector

N/A

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$0.71

Market Cap

14.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSY
CRIS
Founded
2020
2000
Country
China
United States
Employees
20
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6M
14.0M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
DSY
CRIS
Price
$2.81
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.67
AVG Volume (30 Days)
31.0K
123.5K
Earning Date
01-01-0001
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$9,898,000.00
Revenue This Year
N/A
$32.24
Revenue Next Year
N/A
$66.94
P/E Ratio
$16.48
N/A
Revenue Growth
N/A
31.50
52 Week Low
$0.17
$0.75
52 Week High
$4.03
$3.13

Technical Indicators

Market Signals
Indicator
DSY
CRIS
Relative Strength Index (RSI) 60.21 26.34
Support Level $2.66 N/A
Resistance Level $4.02 $1.04
Average True Range (ATR) 0.34 0.08
MACD -0.14 -0.03
Stochastic Oscillator 28.78 8.53

Price Performance

Historical Comparison
DSY
CRIS

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: